tetano
Editor, Senior Moderator
J Cardiol Cases
. 2022 Dec 23.
doi: 10.1016/j.jccase.2022.12.006. Online ahead of print.
Noteworthy sequelae after COVID-19 pneumonia in a patient with heart failure due to cardiomyopathy
Yui Utsugi[SUP] 1 [/SUP], Shingo Kuwata[SUP] 1 [/SUP], Shunichi Doi[SUP] 1 [/SUP], Yukio Sato[SUP] 1 [/SUP], Norio Suzuki[SUP] 1 [/SUP], Masaki Izumo[SUP] 1 [/SUP], Tomoo Harada[SUP] 1 [/SUP], Yuki Ishibashi[SUP] 1 [/SUP], Yoshihiro J Akashi[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is endemic worldwide. Cardiovascular disease, particularly myocarditis, is one of the most common comorbidities in patients with COVID-19. However, heart failure due to COVID-19-triggered cardiomyopathy is not well understood. Additionally, "pseudo" heart failure symptoms have been reported in patients with a compensated condition, in which the heart works well enough that symptoms are unnoticeable or very easy to manage. Here, we report a case of heart failure due to cardiomyopathy in a patient with COVID-19 and postural orthostatic tachycardia syndrome after heart failure treatment. Learning objective. Postural orthostatic tachycardia syndrome (POTS) symptoms after coronavirus disease 2019 may be mistaken for heart failure symptoms; thus, it is essential to suspect POTS when symptoms such as shortness of breath and palpitations are noted upon standing, along with the relevant physical findings.
Keywords: Cardiomyopathy; Coronavirus disease 2019; Postural orthostatic tachycardia syndrome.
. 2022 Dec 23.
doi: 10.1016/j.jccase.2022.12.006. Online ahead of print.
Noteworthy sequelae after COVID-19 pneumonia in a patient with heart failure due to cardiomyopathy
Yui Utsugi[SUP] 1 [/SUP], Shingo Kuwata[SUP] 1 [/SUP], Shunichi Doi[SUP] 1 [/SUP], Yukio Sato[SUP] 1 [/SUP], Norio Suzuki[SUP] 1 [/SUP], Masaki Izumo[SUP] 1 [/SUP], Tomoo Harada[SUP] 1 [/SUP], Yuki Ishibashi[SUP] 1 [/SUP], Yoshihiro J Akashi[SUP] 1 [/SUP]
Affiliations
- PMID: 36575713
- PMCID: PMC9780634
- DOI: 10.1016/j.jccase.2022.12.006
Abstract
Coronavirus disease 2019 (COVID-19) is endemic worldwide. Cardiovascular disease, particularly myocarditis, is one of the most common comorbidities in patients with COVID-19. However, heart failure due to COVID-19-triggered cardiomyopathy is not well understood. Additionally, "pseudo" heart failure symptoms have been reported in patients with a compensated condition, in which the heart works well enough that symptoms are unnoticeable or very easy to manage. Here, we report a case of heart failure due to cardiomyopathy in a patient with COVID-19 and postural orthostatic tachycardia syndrome after heart failure treatment. Learning objective. Postural orthostatic tachycardia syndrome (POTS) symptoms after coronavirus disease 2019 may be mistaken for heart failure symptoms; thus, it is essential to suspect POTS when symptoms such as shortness of breath and palpitations are noted upon standing, along with the relevant physical findings.
Keywords: Cardiomyopathy; Coronavirus disease 2019; Postural orthostatic tachycardia syndrome.